# IGC Pharma, Inc.: Form 8-K, filed Oct 1, 2025

- Company: [IGC Pharma, Inc.](/companies/igc.md) (CIK 1326205)
- Form: 8-K
- Filed: 2025-10-01
- Accepted by EDGAR: Oct 1, 2025, 16:40 ET
- Period: 2025-10-01
- Accession: 0001185185-25-001326
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1326205/000118518525001326/igc8k100125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1326205/000118518525001326/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1326205/000118518525001326/igc8k100125.htm

Filed Oct 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001185185-25-001326. Last ingested by Listed: Nov 6, 2026, 16:27 ET. No prices; not investment advice.